Cleaning data is no longer an afterthought; it’s a continuous, risk-based must-have that protects integrity, ensures compliance, and drives reliable results.
- Human-In-The-Loop In AI Validation And Control: From Principle To Practice
- When The System Breaks, Who Pays? SCRS On Site Tech Gaps
- HTA, Digital Twins, And Building Clinical Tech That Lasts
- Real-World Evidence And Wearables Are Reshaping Trial Tech
- Navigating Elsa's AI Transition: Practical Guidance To Safeguard Confidential Information (Part 3)
- HEOR, AI, And The Future Of Clinical Trial Technology
- AI Amplifies Capabilities But Also Risks: Learn The Legal Consequences Of AI In Clinical Research
- Is It Time To Replace RECIST — Or Just Add AI?
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Gradually Investing In Direct Data Capture Is Inevitable
Given study decentralization and the many electronic sources of data now available, it is time for sponsors and contract research organizations to face the inevitable: EDCs need to be “sunsetted.”
-
How Long Is Your RTSM Risk Mitigation List?
While RTSM systems help reduce many of the risks in clinical trials, each trial’s unique setup necessitates a risk analysis to identify trial-specific challenges.
-
The Role Of AI Throughout The Clinical Research Journey
AI revolutionizes clinical trials by optimizing study design, automating processes, enhancing patient-centric approaches, and providing real-time insights.
-
Unify Your Data With A Centralized eClinical Platform
Despite the challenges associated with large volumes of data, maintaining quality and regulatory compliance, and enhancing patient engagement, the solutions for managing them can be simple and efficient.
-
How SaaS Unlocks New Possibilities For Life Science Organizations
The rise of SaaS (software-as-a-service) has transformed industries, including life sciences, by enabling new possibilities. See how it’s already helping life science organizations around the world today.
-
How Partnership Ensured A Successful First Digital Trial
Discover how this collaborative approach and tailored recommendations led to the successful implementation of an eConsent tool for a kidney cancer study with U.S. Renal Care.
-
Streamlining Clinical Supply With Advanced Automation
Clinical trials are the backbone of pharmaceutical advancements, but they come with their own set of challenges, particularly in data management and supply chain logistics.
-
Everest Group Life Sciences EDC Products PEAK Matrix® Assessment 2024
This Everest Group report examines Medidata’s Rave EDC and its impact on the clinical development value chain of life sciences.
-
3 Aspects To Consider When Selecting Your Next EDC Solution
Not all electronic data collection systems are of the same quality or have the same key features. When selecting an EDC provider, keep these three aspects in mind.
-
Breaking Down Barriers: Why Closed Technology Ecosystems Are Holding Back Clinical Research
Explore the barriers created by closed technology ecosystems and the importance of open, interoperable solutions for advancing healthcare.
- Why Clinical Trial Data Cleaning Must Go Continuous (And How To Do It)
- Sites Are Building Their Own Tech – SCRS On What That Means
- When The System Breaks, Who Pays? SCRS On Site Tech Gaps
- HTA, Digital Twins, And Building Clinical Tech That Lasts
- Real-World Evidence And Wearables Are Reshaping Trial Tech
RECENT NEWSLETTERS
- 05.02.26 -- Best Of April: AI In Clinical Trials — What Working
- 04.30.26 -- AI, RWE & Predictive Analytics Are Reshaping Trials
- 04.23.26 -- Smarter Trials Start Here: Data Quality, AI & Infrastructure Insights
- 04.16.26 -- 5 eTMF Questions, Agentic AI's Real Impact On Clinical Trials & More
- 04.09.26 -- AI In Clinical Trials: Recruitment, eCOA Risks & Data